MedTrace Logo

Amino Acid Infusion in Kidney Transplant Recipients

NCT06929637 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-04-16

No results posted yet for this study

Summary

The study addresses the impact of amino acid infusion in the early post-transplant period on graft function and the incidence of post-transplant complications.

Conditions

  • Short-term Graft Function
  • Metabolic Effects
  • Nutritional Effect
  • Immunological &Amp; Inflammatory Markers
  • Safety
  • Adverse Events

Interventions

DRUG

Infusion Therapy

Infusion of amino acids once daily - dose 1g/kg, maximum 100 g daily for 3 consecutive days starting D1 after kidney transplantation procedure

DRUG

Saline solution infusion

Infusion of saline solution a s standard rehydration therapy after kidney transplantation

Sponsors & Collaborators

  • University Hospital, Martin

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2028-09-15
Completion
2029-01-01

Countries

  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06929637 on ClinicalTrials.gov